{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T08:13:08Z","timestamp":1782461588139,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Kyowa Kirin"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s12325-019-01170-7","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T18:04:20Z","timestamp":1585677860000},"page":"105-112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Complications of Phosphate and Vitamin D Treatment in X-Linked Hypophosphataemia"],"prefix":"10.1007","volume":"37","author":[{"given":"Pedro","family":"Arango Sancho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"issue":"10","key":"1170_CR1","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1210\/jc.2015-3229","volume":"100","author":"MJ Econs","year":"2015","unstructured":"Econs MJ. Conventional therapy in adults with XLH improves dental manifestations, but not enthesopathy. J Clin Endocrinol Metab. 2015;100(10):3622\u20134.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1170_CR2","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/EC-13-0103","volume":"3","author":"A Linglart","year":"2014","unstructured":"Linglart A, Biosse-Duplan M, Briot K, et al. Therapeutic management of hypophosphatemic rickets from infancy to adulthood. Endocr Connect. 2014;3(1):R13\u201330.","journal-title":"Endocr Connect"},{"issue":"7","key":"1170_CR3","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/jbmr.340","volume":"26","author":"TO Carpenter","year":"2011","unstructured":"Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL. A clinician\u2019s guide to X-linked hypophosphatemia. J Bone Miner Res. 2011;26(7):1381\u20138.","journal-title":"J Bone Miner Res"},{"key":"1170_CR4","volume-title":"Endotext","author":"TO Carpenter","year":"2000","unstructured":"Carpenter TO. Primary disorders of phosphate metabolism. In: Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, editors. Endotext. South Dartmouth: MDText.com; 2000."},{"issue":"8","key":"1170_CR5","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1210\/jc.2003-030036","volume":"88","author":"O Makitie","year":"2003","unstructured":"Makitie O, Doria A, Kooh SW, Cole WG, Daneman A, Sochett E. Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab. 2003;88(8):3591\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1170_CR6","first-page":"A4874","volume":"61","author":"LH Nielsen","year":"2014","unstructured":"Nielsen LH, Rahbek ET, Beck-Nielsen SS, Christesen HT. Treatment of hypophosphataemic rickets in children remains a challenge. Dan Med J. 2014;61(7):A4874.","journal-title":"Dan Med J"},{"issue":"3","key":"1170_CR7","first-page":"529","volume":"54","author":"F Albright","year":"1937","unstructured":"Albright F, Butler AN, Bloomberg E. Rickets resistant to vitamin D therapy. Am J Dis Child. 1937;54(3):529\u201347.","journal-title":"Am J Dis Child"},{"issue":"3","key":"1170_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1651-2227.1969.tb04709.x","volume":"58","author":"GB Stickler","year":"1969","unstructured":"Stickler GB. Familial hypophosphatemic vitamin D resistant rickets. The neonatal period and infancy. Acta Paediatr Scand. 1969;58(3):213\u20139.","journal-title":"Acta Paediatr Scand"},{"issue":"6","key":"1170_CR9","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S0022-3476(68)80236-7","volume":"73","author":"L Paunier","year":"1968","unstructured":"Paunier L, Kooh SW, Conen PE, Gibson AA, Fraser D. Renal function and histology after long-term vitamin D therapy of vitamin D refractory rickets. J Pediatr. 1968;73(6):833\u201344.","journal-title":"J Pediatr"},{"issue":"1","key":"1170_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/jn\/9.1.25","volume":"9","author":"CA Lilly","year":"1935","unstructured":"Lilly CA, Peirce CB, Grant RL. The effect of phosphates on the bones of rachitic rats: three plates (twelve figures). J Nutr. 1935;9(1):25\u201335.","journal-title":"J Nutr"},{"issue":"4","key":"1170_CR11","first-page":"460","volume":"96","author":"D Fraser","year":"1958","unstructured":"Fraser D, Geiger DW, Munn JD, Slater PE, Jahn R, Liu E. Clinical vitamin-D deficiency and in hypophosphatemic vitamin-D-refractory rickets-the induction of calcium deposition in rachitic cartilage without the administration of vitamin-D. Am J Dis Child. 1958;96(4):460\u20133.","journal-title":"Am J Dis Child"},{"issue":"3","key":"1170_CR12","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1210\/endo-111-3-904","volume":"111","author":"PJ Marie","year":"1982","unstructured":"Marie PJ, Travers R, Glorieux FH. Healing of bone lesions with 1,25-dihydroxyvitamin D3 in the young X-linked hypophosphatemic male mouse. Endocrinology. 1982;111(3):904\u201311.","journal-title":"Endocrinology"},{"issue":"6","key":"1170_CR13","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1172\/JCI111900","volume":"75","author":"RM Harrell","year":"1985","unstructured":"Harrell RM, Lyles KW, Harrelson JM, Friedman NE, Drezner MK. Healing of bone disease in X-linked hypophosphatemic rickets\/osteomalacia. Induction and maintenance with phosphorus and calcitriol. J Clin Invest. 1985;75(6):1858\u201368.","journal-title":"J Clin Invest"},{"issue":"2","key":"1170_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/BF02556466","volume":"44","author":"JE Block","year":"1989","unstructured":"Block JE, Piel CF, Selvidge R, Genant HK. Familial hypophosphatemic rickets: bone mass measurements in children following therapy with calcitriol and supplemental phosphate. Calcif Tissue Int. 1989;44(2):86\u201392.","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"1170_CR15","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1055\/s-0029-1212011","volume":"106","author":"A Haris","year":"1998","unstructured":"Haris A, Toth A, Rado JP. High-dose phosphate treatment leads to hypokalemia in hypophosphatemic osteomalacia. Exp Clin Endocrinol Diabetes. 1998;106(5):431\u20134.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"2","key":"1170_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00467-010-1705-9","volume":"26","author":"M Zivicnjak","year":"2011","unstructured":"Zivicnjak M, Schnabel D, Billing H, et al. Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets. Pediatr Nephrol. 2011;26(2):223\u201331.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"1170_CR17","first-page":"123","volume":"17","author":"SW Kooh","year":"1994","unstructured":"Kooh SW, Binet A, Daneman A. Nephrocalcinosis in X-linked hypophosphataemic rickets: its relationship to treatment, kidney function, and growth. Clin Invest Med. 1994;17(2):123\u201330.","journal-title":"Clin Invest Med"},{"issue":"1","key":"1170_CR18","first-page":"483","volume":"7","author":"VL Sellar\u00e9s","year":"2012","unstructured":"Sellar\u00e9s VL, Mart\u00edn de Francisco AL, Torregrosa V. Alteraciones del metabolismo mineral en la enfermedad renal cr\u00f3nica. Nefrologia. 2012;7(1):483\u2013503.","journal-title":"Nefrologia"},{"issue":"2","key":"1170_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1365-2265.1995.tb01864.x","volume":"42","author":"M Davies","year":"1995","unstructured":"Davies M. Hyperparathyroidism in X-linked hypophosphataemic osteomalacia. Clin Endocrinol (Oxf). 1995;42(2):205\u20136.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3999","key":"1170_CR20","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1126\/science.173.3999.845","volume":"173","author":"C Arnaud","year":"1971","unstructured":"Arnaud C, Glorieux F, Scriver C. Serum parathyroid hormone in X-linked hypophosphatemia. Science. 1971;173(3999):845\u20137.","journal-title":"Science"},{"issue":"11","key":"1170_CR21","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1007\/s004310050962","volume":"157","author":"K Kruse","year":"1998","unstructured":"Kruse K, Hinkel GK, Griefahn B. Calcium metabolism and growth during early treatment of children with X-linked hypophosphataemic rickets. Eur J Pediatr. 1998;157(11):894\u2013900.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"1170_CR22","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S0022-3476(87)80245-7","volume":"111","author":"PR Goodyer","year":"1987","unstructured":"Goodyer PR, Kronick JB, Jequier S, Reade TM, Scriver CR. Nephrocalcinosis and its relationship to treatment of hereditary rickets. J Pediatr. 1987;111(5):700\u20134.","journal-title":"J Pediatr"},{"key":"1170_CR23","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.bone.2019.06.025","volume":"127","author":"S DeLacey","year":"2019","unstructured":"DeLacey S, Liu Z, Broyles A, et al. Hyperparathyroidism and parathyroidectomy in X-linked hypophosphatemia patients. Bone. 2019;127:386\u201392.","journal-title":"Bone"},{"issue":"18","key":"1170_CR24","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1056\/NEJM198010303031802","volume":"303","author":"FH Glorieux","year":"1980","unstructured":"Glorieux FH, Marie PJ, Pettifor JM, Delvin EE. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med. 1980;303(18):1023\u201331.","journal-title":"N Engl J Med"},{"issue":"2","key":"1170_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1046\/j.1365-2265.2003.01685.x","volume":"58","author":"O Makitie","year":"2003","unstructured":"Makitie O, Kooh SW, Sochett E. Prolonged high-dose phosphate treatment: a risk factor for tertiary hyperparathyroidism in X-linked hypophosphatemic rickets. Clin Endocrinol (Oxf). 2003;58(2):163\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1170_CR26","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/MNH.0000000000000327","volume":"26","author":"N Jain","year":"2017","unstructured":"Jain N, Reilly RF. Hungry bone syndrome. Curr Opin Nephrol Hypertens. 2017;26(4):250\u20135.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"3","key":"1170_CR27","doi-asserted-by":"publisher","first-page":"658","DOI":"10.2215\/CJN.04981107","volume":"3","author":"US Alon","year":"2008","unstructured":"Alon US, Levy-Olomucki R, Moore WV, Stubbs J, Liu S, Quarles LD. Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets. Clin J Am Soc Nephrol. 2008;3(3):658\u201364.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1170_CR28","first-page":"1684","volume":"29","author":"S Chocron","year":"2014","unstructured":"Chocron S, Lara LE, Madrid A, Mu\u00f1oz M, Vilalta R, Ariceta G. Cinacalcet allows reduction of oral phosphate dose and PTH control in XLHR. Preliminary data. Pediatr Nephrol. 2014;29:1684 (Abstract O78).","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"1170_CR29","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.clinthera.2005.11.015","volume":"27","author":"BJ Dong","year":"2005","unstructured":"Dong BJ. Cinacalcet: an oral calcimimetic agent for the management of hyperparathyroidism. Clin Ther. 2005;27(11):1725\u201351.","journal-title":"Clin Ther"},{"issue":"5","key":"1170_CR30","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1517\/14656566.9.5.795","volume":"9","author":"AL de Francisco","year":"2008","unstructured":"de Francisco AL. New strategies for the treatment of hyperparathyroidism incorporating calcimimetics. Expert Opin Pharmacother. 2008;9(5):795\u2013811.","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"1170_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00467-002-1044-6","volume":"18","author":"US Alon","year":"2003","unstructured":"Alon US, Monzavi R, Lilien M, Rasoulpour M, Geffner ME, Yadin O. Hypertension in hypophosphatemic rickets\u2014role of secondary hyperparathyroidism. Pediatr Nephrol. 2003;18(2):155\u20138.","journal-title":"Pediatr Nephrol"},{"key":"1170_CR32","unstructured":"Colares Neto G, Yamamuchi FI, Baroni RH, et al. Nephrocalcinosis and nephrolithiasis in 36 X-linked hypophosphatemic rickets patients: diagnostic imaging and evaluation of risk factors in a single-center study (Poster 218-P2). In: 51st Annual Meeting European Society of Paediatric Endocrinology (ESPE); 2015 October 1\u20133; Barcelona, Spain."},{"issue":"6","key":"1170_CR33","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1542\/peds.71.6.970","volume":"71","author":"U Alon","year":"1983","unstructured":"Alon U, Brewer WH, Chan JC. Nephrocalcinosis: detection by ultrasonography. Pediatrics. 1983;71(6):970\u20133.","journal-title":"Pediatrics"},{"issue":"11\u201312","key":"1170_CR34","first-page":"1333","volume":"28","author":"M Keskin","year":"2015","unstructured":"Keskin M, Savas-Erdeve S, Sagsak E, Cetinkaya S, Aycan Z. Risk factors affecting the development of nephrocalcinosis, the most common complication of hypophosphatemic rickets. J Pediatr Endocrinol Metab. 2015;28(11\u201312):1333\u20137.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"12","key":"1170_CR35","doi-asserted-by":"publisher","first-page":"5906","DOI":"10.1210\/en.2012-1551","volume":"153","author":"AC Karaplis","year":"2012","unstructured":"Karaplis AC, Bai X, Falet JP, Macica CM. Mineralizing enthesopathy is a common feature of renal phosphate-wasting disorders attributed to FGF23 and is exacerbated by standard therapy in hyp mice. Endocrinology. 2012;153(12):5906\u201317.","journal-title":"Endocrinology"},{"issue":"1","key":"1170_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM198507043130101","volume":"313","author":"RP Polisson","year":"1985","unstructured":"Polisson RP, Mart\u00ednez S, Khoury M, et al. Calcification of entheses associated with X-linked hypophosphatemic osteomalacia. N Engl J Med. 1985;313(1):1\u20136.","journal-title":"N Engl J Med"},{"issue":"4","key":"1170_CR37","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/00008480-200108000-00015","volume":"13","author":"KC Moltz","year":"2001","unstructured":"Moltz KC, Friedman AH, Nehgme RA, Kleinman CS, Carpenter TO. Ectopic cardiac calcification associated with hyperparathyroidism in a boy with hypophosphatemic rickets. Curr Opin Pediatr. 2001;13(4):373\u20135.","journal-title":"Curr Opin Pediatr"},{"issue":"5","key":"1170_CR38","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1542\/peds.100.5.879","volume":"100","author":"MG Seikaly","year":"1997","unstructured":"Seikaly MG, Brown R, Baum M. The effect of recombinant human growth hormone in children with X-linked hypophosphatemia. Pediatrics. 1997;100(5):879\u201384.","journal-title":"Pediatrics"},{"issue":"4","key":"1170_CR39","first-page":"212","volume":"69","author":"O Makitie","year":"2008","unstructured":"Makitie O, Toiviainen-Salo S, Marttinen E, Kaitila I, Sochett E, Sipila I. Metabolic control and growth during exclusive growth hormone treatment in X-linked hypophosphatemic rickets. Horm Res. 2008;69(4):212\u201320.","journal-title":"Horm Res"},{"issue":"4","key":"1170_CR40","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1530\/eje.0.1490317","volume":"149","author":"SM Sch\u00fctt","year":"2003","unstructured":"Sch\u00fctt SM, Schumacher M, Holterhus PM, Felgenhauer S, Hiort O. Effect of GH replacement therapy in two male siblings with combined X-linked hypophosphatemia and partial GH deficiency. Eur J Endocrinol. 2003;149(4):317\u201321.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1170_CR41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1161\/ATVBAHA.110.214619","volume":"31","author":"MA Mirza","year":"2011","unstructured":"Mirza MA, Alsio J, Hammarstedt A, et al. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals. Arterioscler Thromb Vasc Biol. 2011;31(1):219\u201327.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"1170_CR42","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul C, Amaral AP, Oskouei B, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011;121(11):4393\u2013408.","journal-title":"J Clin Invest"},{"issue":"11","key":"1170_CR43","doi-asserted-by":"publisher","first-page":"E352","DOI":"10.1210\/jc.2010-0589","volume":"95","author":"TO Carpenter","year":"2010","unstructured":"Carpenter TO, Insogna KL, Zhang JH, et al. Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status. J Clin Endocrinol Metab. 2010;95(11):E352\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1170_CR44","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1359\/jbmr.080417","volume":"23","author":"Y Yamazaki","year":"2008","unstructured":"Yamazaki Y, Tamada T, Kasai N, et al. Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23. J Bone Miner Res. 2008;23(9):1509\u201318.","journal-title":"J Bone Miner Res"},{"issue":"11","key":"1170_CR45","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1359\/jbmr.090509","volume":"24","author":"Y Aono","year":"2009","unstructured":"Aono Y, Yamazaki Y, Yasutake J, et al. Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets\/osteomalacia. J Bone Miner Res. 2009;24(11):1879\u201388.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1170_CR46","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1172\/JCI72829","volume":"124","author":"TO Carpenter","year":"2014","unstructured":"Carpenter TO, Imel EA, Ruppe MD, et al. Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia. J Clin Invest. 2014;124(4):1587\u201397.","journal-title":"J Clin Invest"},{"issue":"21","key":"1170_CR47","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","volume":"378","author":"TO Carpenter","year":"2018","unstructured":"Carpenter TO, Whyte MP, Imel EA, et al. Burosumab therapy in children with X-linked hypophosphatemia. N Engl J Med. 2018;378(21):1987\u201398.","journal-title":"N Engl J Med"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01170-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-019-01170-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01170-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T03:18:48Z","timestamp":1666235928000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-019-01170-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":47,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1170"],"URL":"https:\/\/doi.org\/10.1007\/s12325-019-01170-7","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,31]]},"assertion":[{"value":"11 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}